NEWS UPDATE
China faces acute revenue crunch! Will it reform clunky fiscal system? Erroneous Refund Has Globalisation favoured capital more than labour? Can taxing super-rich help? Global Debt & Fiscal Silhouette rising! Do Elections contribute to fiscal slippages? Tax Refund Conundrum - Odyssey of Legal Missteps Tax - on Death and Contemplation Right to Sleep - A Legal lullaby Nexus between Election Manifesto and Budget 2024 in July! GST Penalty of Rs. 3731 Crores on an employee! TIOL Fiscal Awards: Maastricht is dead & gone! What next? When the Stars Aligned: An Evening at the TIOL Awards Kudos for Digitalisation vs Pillories for e-waste! Import of Obscene goods - Who decides obscenity - Customs? EV Revolution: Lessons for India to learn from US and China! Massager or sex toy? One Nation, Many Elections: Time to repair the feet of clay! Too Many Sleuths Spoil the GST Soup WTO needs active aid-in-dying! China favours alternative trade architecture! GST in Income tax The Rhetoric of Illusory Decoupling of American Economy from Chinese! Where is that GST Appellate Tribunal? Trump's return to Oval Office! China sweating like just out of heated hammam! Cached Cash and GST America to quit NATO! A case of more theatre than threat! Aha, Trumpian in flavour! Doctrine of Proportionality Global Trade: Ruptured geopolitical order letting Red Sea turn 'Redder'! Templated Show Cause Notice - GST Ishtyle Interim Budget 2024: Quo Vadis, Indian Economy? Personal Hearing - By Law, Not Discretion Interim Budget 2024: Will FM really play fiscal 'Santa Claus' today! Sweet Beginning - Halwa Served - Budget Interim US Presidential Election: 'Tariff Man' is coming! Take cover! Summons - power of pen more effective than the presence of an officer in court Mamma mia! Nationalism-tinged AI may derail 'Re-globalisation'! PM visits GST Academy Din over DIN: What is FOMO for CBIC is actually JOMO for CBDT! Arrest under PMLA

Print

GST has done good to pharma sector; Turnover up by 6%: Minister

Published: Nov 15, 2018

By TIOL News Service

NEW DELHI, NOV 15, 2018: IMPACT of Goods and Services Tax (GST) on Pharma sector has largely been positive and constructive, informed Minister of State for Road Transport, Highways, Shipping and Chemicals & Fertilizers, Mr Mansukh Mandaviya, in a statement here today. Following the vision of Prime Minister of India, Mr Narendra Modi, to ensure health security for all citizens of India, the Ministry of Chemicals & Fertilizers has taken various steps to ensure availability of ‘Affordable, Quality Medicines for All', the Minister added.

In this background, Mr Mandaviya informed that the Pharma sector has seen a positive growth after the implementation of GST. This is evident from the following:-

Before GST,  Annual Turnover of the Pharma Sector  (as on 31.05.2017) was Rs 1,14,231 crores while after GST, the Annual Turnover of Pharma sector (as on 31.05.2018) touched Rs 1,31,312 crores, which is 6% higher than the Pre-GST regime.

Exports from Pharma Sector  during 2016-17 were Rs 2,75,852 crores while post-GST, in the year 2017-18, they were recorded at Rs 3,03,526 crores, which is 10% higher than the Pre-GST Regime. The Minister added that as per estimates, the export figure for the current year is likely to be Rs 3,27,700 crores, which will be almost 12% higher than the export figure of Pre-GST regime (2016-17).

Further, it was informed that there has been a significant jump in number of  Drug Approvals from 7,857 before GST (01.07.2016 to 30.06.2017) to 10,446 post-GST (01.07.2017 to 30.06.2018).

Elaborating on the reasons for this positive impact post-GST, Mr Mandaviya said that under the ‘One Nation, One Tax' regime, the removal of complexity of multiple taxes has reduced their cascading effect on the final product. GST is expected to decrease the manufacturing cost in view of merging of different taxes levied earlier and promote ease of doing business. It will create one single market for all stakeholders with equal chance towards development.

Mr Mandaviya informed that due to discontinuation of Central Sales Tax post-GST, it will reduce transaction costs, as inter-state transaction between two dealers will become tax neutral. Now, the pharma companies can consolidate their warehouses at strategic locations, effecting a reduction in cost of distribution. As a result, it will benefit warehouse strategy and improve supply chain efficiency in pharma sector, the Minister explained.

TIOL SEARCH


A Taxindiaonline Website. Copyright @ 2021 TIOL Pvt.Ltd. All rights reserved.